Details for Patent: 10,376,661

Which drugs does patent 10,376,661 protect, and when does it expire?

Patent 10,376,661 protects LONHALA MAGNAIR KIT and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 10,376,661

Title:	Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element
Abstract:	An opening element for opening an ampoule in an aerosol generation device includes a first member which has a conduit extending therethrough for guiding a fluid contained in the ampoule through the first member and a second member which is arranged at least partly inside or on the conduit. Further, an aerosol generation device includes such an opening element.
Inventor(s):	Gallem; Thomas (Munich, DE), Hetzer; Uwe (Munich, DE), Pham; Stephen (San Diego, CA), Quintana; Reynaldo (Menlo Park, CA)
Assignee:	PARI Pharma GmbH (Starnberg, DE)
Application Number:	14/427,457
Patent Claim Types: see list of patent claims	Delivery; Device;

Drugs Protected by US Patent 10,376,661

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sumitomo Pharma Am	LONHALA MAGNAIR KIT	glycopyrrolate	SOLUTION;INHALATION	208437-001	Dec 5, 2017		DISCN	Yes	No			Y

Foreign Priority and PCT Information for Patent: 10,376,661

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	12184036	Sep 12, 2012

PCT Information
PCT Filed	September 09, 2013	PCT Application Number:	PCT/EP2013/068592
PCT Publication Date:	March 20, 2014	PCT Publication Number:	WO2014/040947

International Family Members for US Patent 10,376,661

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2883583
China	104619303
European Patent Office	2708219
European Patent Office	2895136
Spain	2740549